APA (7th ed.) Citation

J, G., CA, H., & GB, C. (2022). COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy. Journal of nephrology, 35(1), 317. https://doi.org/10.1007/s40620-021-01125-8

Chicago Style (17th ed.) Citation

J, Gill, Hebert CA, and Colbert GB. "COVID-19-associated Atypical Hemolytic Uremic Syndrome and Use of Eculizumab Therapy." Journal of Nephrology 35, no. 1 (2022): 317. https://doi.org/10.1007/s40620-021-01125-8.

MLA (9th ed.) Citation

J, Gill, et al. "COVID-19-associated Atypical Hemolytic Uremic Syndrome and Use of Eculizumab Therapy." Journal of Nephrology, vol. 35, no. 1, 2022, p. 317, https://doi.org/10.1007/s40620-021-01125-8.